Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record page shows a revision label updated from v3.5.3 to v3.5.4, indicating a small update to the page’s metadata. This change does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-15T09:09:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    New bibliographic entries were added to the Publications section, including a 2026 article on checkpoint inhibitors in Hodgkin lymphoma, and a note that PubMed entries may be auto-filled from PubMed.
    Difference
    0.1%
    Check dated 2026-05-08T09:30:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page’s displayed software/version revision number (from v3.5.2 to v3.5.3) occurred, without any visible change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:45:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added updated contact details for study staff (e.g., Matthew Mei, MD; Ranjana Advani, MD) and new location information for Stanford University Medical Center and City of Hope Cancer Center, and revised total study locations from 8 to 10.
    Difference
    0.9%
    Check dated 2026-04-17T02:12:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. This change is a metadata/versioning update and does not alter the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-03-18T22:51:19.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:04:47.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.